Gene · 344
Papers3,206
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,206
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The relationship of remnant cholesterol and abdominal obesity in children: A cross-sectional study. | Front Cardiovasc Med | 2022 | 35966536 | PubTator, text mining | PubMed |
| Local and systemic therapy may be safely de-escalated in elderly breast cancer patients in China: A retrospective cohort study. | Front Oncol | 2022 | 35965508 | PubTator, text mining | PubMed |
| Plasma exchange therapy for familial chylomicronemia syndrome in infant: A case report. | Medicine (Baltimore) | 2022 | 35960041 | PubTator, text mining | PubMed |
| Longitudinal Serum Proteome Characterization of COVID-19 Patients With Different Severities Revealed Potential Therapeutic Strategies. | Front Immunol | 2022 | 35958562 | PubTator, text mining | PubMed |
| Proteomic analysis of plasma exosomes in patients with non-small cell lung cancer. | Transl Lung Cancer Res | 2022 | 35958340 | PubTator, text mining | PubMed |
| Urinary proteomic analysis during pregnancy and its potential application in early prediction of gestational diabetes mellitus and spontaneous abortion. | Ann Transl Med | 2022 | 35957715 | PubTator, text mining | PubMed |
| Plasma proteoforms of apolipoproteins C-I and C-II are associated with plasma lipids in the Multi-Ethnic Study of Atherosclerosis. | J Lipid Res | 2022 | 35952903 | PubTator, text mining | PubMed |
| Membranous Nephropathy-Like Apolipoprotein E Deposition Disease with Apolipoprotein E Toyonaka and Homozygous Apolipoprotein E2/2 without Dyslipidemia, with Characteristic Electron-Dense Deposits. | Case Rep Nephrol Dial | 2022 | 35950048 | PubTator, text mining | PubMed |
| Plasma Apolipoproteins Predicting the Occurrence and Severity of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus. | Front Endocrinol (Lausanne) | 2022 | 35937834 | PubTator, text mining | PubMed |
| Differentially Regulated Apolipoproteins and Lipid Profiles as Novel Biomarkers for Polypoidal Choroidal Vasculopathy and Neovascular Age-Related Macular Degeneration. | Front Endocrinol (Lausanne) | 2022 | 35928899 | PubTator, text mining | PubMed |
| Identifying potential prognosis markers in hepatocellular carcinoma via integrated bioinformatics analysis and biological experiments. | Front Genet | 2022 | 35928445 | PubTator, text mining | PubMed |
| Developmental modeling of hepatogenesis using obese iPSCs-hepatocyte differentiation uncovers pathological features. | Cell Death Dis | 2022 | 35915082 | PubTator, text mining | PubMed |
| Using Synthetic ApoC-II Peptides and nAngptl4 Fragments to Measure Lipoprotein Lipase Activity in Radiometric and Fluorescent Assays. | Front Cardiovasc Med | 2022 | 35911520 | PubTator, text mining | PubMed |
| A Bibliometric Analysis of Research on the Links Between Gut Microbiota and Atherosclerosis. | Front Cardiovasc Med | 2022 | 35903667 | PubTator, text mining | PubMed |
| Tackling Atherosclerosis via Selected Nutrition. | Int J Mol Sci | 2022 | 35897799 | PubTator, text mining | PubMed |
| Identifying Patients with Familial Chylomicronemia Syndrome Using FCS Score-Based Data Mining Methods. | J Clin Med | 2022 | 35893402 | PubTator, text mining | PubMed |
| Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer's Disease. | Genes (Basel) | 2022 | 35893045 | PubTator, text mining | PubMed |
| New Therapeutic Approaches in Treatment of Dyslipidaemia-A Narrative Review. | Pharmaceuticals (Basel) | 2022 | 35890138 | PubTator, text mining | PubMed |
| Differential Protein Expression among Two Different Ovine ARDS Phenotypes-A Preclinical Randomized Study. | Metabolites | 2022 | 35888779 | PubTator, text mining | PubMed |
| Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies. | Front Pharmacol | 2022 | 35873564 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/344/papers?page=24